Viewing StudyNCT06304961



Ignite Creation Date: 2024-05-06 @ 8:13 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06304961
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2024-03-05

Brief Title: A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-04-08
Start Date Type: ACTUAL
Primary Completion Date: 2024-09-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-09-06
Completion Date Type: ESTIMATED
First Submit Date: 2024-03-05
First Submit QC Date: March 5 2024
Study First Post Date: 2024-03-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-16
Last Update Post Date: 2024-05-29
Last Update Post Date Type: ACTUAL